Activity

With the onset of the COVID-19 pandemic, researchers have been faced with challenges in maintaining interdisciplinary research collaborations. The purpose of this article is to apply and expand a previously introduced model to sustaining new interdisciplinary research collaborations Forging Alliances in Interdisciplinary Rehabilitation Research (FAIRR). FAIRR is a logic model that can be used as a guide to create interdisciplinary rehabilitation research teams. In this article, the authors propose expanding FAIRR by including strategies for sustaining interdisciplinary rehabilitation research collaborations modifying inputs (resources needed to assemble a team and to conduct research activities), shifting activities (steps taken to move the interdisciplinary collaboration forward), and examining what impacts the fit between inputs and activities. Two examples are used to highlight the application of the FAIRR model to interdisciplinary collaborations during COVID-19.

With the onset of the COVID-19 pandemic, researchers have been faced with challenges in maintaining interdisciplinary research collaborations. The purpose of this article is to apply and expand a previously introduced model to sustaining new interdisciplinary research collaborations Forging Alliances in Interdisciplinary Rehabilitation Research (FAIRR). FAIRR is a logic model that can be used as a guide to create interdisciplinary rehabilitation research teams. In this article, the authors propose expanding FAIRR by including strategies for sustaining interdisciplinary rehabilitation research collaborations modifying inputs (resources needed to assemble a team and to conduct research activities), shifting activities (steps taken to move the interdisciplinary collaboration forward), and examining what impacts the fit between inputs and activities. Two examples are used to highlight the application of the FAIRR model to interdisciplinary collaborations during COVID-19.

The Association of Academic Physiatrists (AAP), the home of academic physiatry, is interested in advancing industry partnerships in research among academic physiatrists. There are limited existing resources that outline opportunities for academic physiatrists in engaging the translational research continuum through industry partnerships and the skillsets that academic physiatrists need to successfully navigate these partnerships. In 2019, then President of the AAP, John Chae, MD, ME assembled a group of interested physician-scientists in physical medicine & rehabilitation (PM&R) to form the Research and Industry Partnerships Task Force to address this problem. The Task Force implemented a live educational session titled “Collaborating with Industry” at Physiatry ’19, the Annual Meeting of the AAP held in Puerto Rico. To extend the reach of this valuable information, the Task Force is creating resources that can be easily distributed and accessed by all physiatrists. The goal of this white paper is tAAP held in Puerto Rico. To extend the reach of this valuable information, the Task Force is creating resources that can be easily distributed and accessed by all physiatrists. The goal of this white paper is to provide a roadmap to help academic physiatrists begin to navigate the field of academia-industry relationships with the ultimate goal of accelerating discovery for the benefit of physiatry and rehabilitation patients.

Medication use among elite athletes has received growing attention over the past decades. However, only limited studies have focused on para athletes and trends in medication use among this cohort, remain unclear. The aims of this study were 1) to describe the pattern of medication use in elite Paralympic athletes, with a particular focus on analgesics, 2) to analyse whether medications declared by athletes were included in the 2018 World Anti-Doping Agency (WADA) Prohibited List and Monitoring Program, 3) to report on a variety of novel supplements, and 4) to review whether athlete analgesic needs will be met by the new Olympic & Paralympic Model Formulary (OPMF).DESIGNRetrospective, descriptive cohort study.

Of all athletes who underwent doping control, 21% declared the use of an analgesic medication. Athletes with limb deficiency and para-snowboarders declared the most analgesic medications in their respective categories. It was determined that 84% of the athletes’ analgesic medication needs were provided from the new OPMF.

Analgesic use among athletes who participated at the 2018 PyeongChang Winter Paralympics was high. Para-snowboarders and athletes with limb deficiency declared the most analgesics. The new OPMF adequately addressed the medication needs of the athletes attending the 2018 Games.

Analgesic use among athletes who participated at the 2018 PyeongChang Winter Paralympics was high. Para-snowboarders and athletes with limb deficiency declared the most analgesics. The new OPMF adequately addressed the medication needs of the athletes attending the 2018 Games.

The objective of this retrospective, longitudinal study was to investigate the prevalence of drinking within the recommended limits (i.e., low-risk drinking) following moderate/severe traumatic brain injury (TBI). selleck products Data were drawn from the National Institute on Disability, Independent Living, and Rehabilitation Research TBI Model Systems National Database (TBIMS), a longitudinal dataset closely representative of the U.S. adult population requiring inpatient rehabilitation for TBI. The sample included 6,348 adults with moderate or severe TBI (injured October 2006 – May 2016) who received inpatient rehabilitation at a civilian TBIMS center and completed the alcohol consumption items for pre-injury, and 1- and 2-year post-injury. National Institute on Alcohol Abuse and Alcoholism (NIAAA) guidelines define low-risk drinking as no more than 4 drinks per day for men or 3 drinks per day for women, and no more than 14 drinks per week for men, or no more than 7 drinks per week for women. Low-risk drinking was common S center and completed the alcohol consumption items for pre-injury, and 1- and 2-year post-injury. National Institute on Alcohol Abuse and Alcoholism (NIAAA) guidelines define low-risk drinking as no more than 4 drinks per day for men or 3 drinks per day for women, and no more than 14 drinks per week for men, or no more than 7 drinks per week for women. Low-risk drinking was common both before and after TBI, with more than 30% drinking in the low-risk level pre- injury, and more than 25% at 1- and 2-years post-injury. Post-injury, the majority of drinkers consumed alcohol in the low-risk level regardless of pre-injury drinking level. Definitive research on the long-term outcomes of low-risk alcohol consumption following more severe TBI should be a high priority.